Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Though Wegovy and Mounjaro clearly have been able to be commercially successful, additional entrants into the sector may struggle unless insurers in the US change their stance
Lilly's dual GLP-1/GIP agonist reached Phase 3 in 2019 and read out body-weight reductions of roughly 22% at the 15 mg dose in SURMOUNT-1, meaningfully above semaglutide's ~15%
Want to Try Allulose
Additionally, this symptom is not found in medical literature about the medication or in clinical trials
US$ 21.94
US$ 27.94
US$ 29.14
US$ 20.99
![Fragment [1-25]-Tirzepatide](https://www.daicelpharmastandards.com/wp-content/uploads/2025/04/dcti-d-571.png)
US$ 26.82
US$ 23.17
US$ 20.74
US$ 28.83
US$ 24.00
US$ 25.57
US$ 26.18
